Metabolic syndrome (MetS) is characterised by a number of components that are associated with accelerated arterial ageing and cardiovascular events. These include raised blood pressure, dyslipidaemia, raised fasting glucose and central obesity. Research across a European cohort has suggested that MetS has a prevalence of 24.3%.
